André Luxen
About
In The Last Decade
André Luxen
297 papers receiving 17.1k citations
Hit Papers
Peers
Comparison fields: 5 of 189
- Cognitive Neuroscience 10.0k
- Experimental and Cognitive Psychology 3.1k
- Radiology, Nuclear Medicine and Imaging 2.5k
- Cellular and Molecular Neuroscience 2.3k
- Psychiatry and Mental health 1.8k
Countries citing papers authored by André Luxen
This map shows the geographic impact of André Luxen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Luxen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Luxen more than expected).
Fields of papers citing papers by André Luxen
This network shows the impact of papers produced by André Luxen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Luxen. The network helps show where André Luxen may publish in the future.
Co-authorship network of co-authors of André Luxen
This figure shows the co-authorship network connecting the top 25 collaborators of André Luxen. A scholar is included among the top collaborators of André Luxen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Luxen. André Luxen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 6 | |
| 3 | 47 | |
| 4 | Absorbed doses to mice for three [18F]-tracers calculated from experimental kinetic data and Monte Carlo simulations | 1 |
| 5 | Dosimetry for 6-[18F]Fluoro-L-DOPA in humans based on in vivo microPET scans and ex vivo tissue distribution in mice | 1 |
| 6 | 478 | |
| 7 | New Improvements in the Enantioselective Synthesis of 2-[18F]Fluoro-L-Tyrosine and 6-[18F]Fluoro-L-Dopa | 1 |
| 8 | Large Scale Preparation of [18]Fluoromethoxybenzyl Bromides, Key Precursors for 2-[18F]Fluoro-L-Tyrosine and 6-[18F]Fluoro-L-Dopa | 1 |
| 9 | Automated synthesis of [18F]fallypride for imaging dopamine D2 receptors | 2 |
| 10 | Method for the preparation of reactive [18F]fluoride | 1 |
| 11 | Influence of P-glycoprotein on the tissue distribution in rats of the 5-HT1A antagonist p-[18F]MPPF. | 1 |
| 12 | Brain function during vegetative state and after recovery: A lesional approach to the study of human consciousness | 1 |
| 13 | 5-HT1A receptor distribution in the human brain: preliminary PET data with p-[18F]MPPF. | 1 |
| 14 | Contribution of long-term memory to working memory tasks. A PET activation study | 1 |
| 15 | The synthesis of 6-[18F]fluoro-L-dopa by chiral catalytic phase-transfer alkylation. | 3 |
| 16 | Evaluation of p-[F-18]MPPF, 5-HT1A antagonist, in rats: tissue distribution, autoradiography and metabolism. | 2 |
| 17 | Synthesis of [18F]FDG with alkaline hydrolysis on a low polarity solid phase support. | 2 |
| 18 | Fast quality control of short-lived radiopharmaceutical compounds with a photodiode array detector. | 1 |
| 19 | Sep Pak as alternative to rotary evaporators for radiopharmaceutical formulations. | 3 |
| 20 | S-, N- and O-[11C]methylations of a Nor precursor adsorbed on Al2O3/KF. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.